There were 1,861 press releases posted in the last 24 hours and 399,322 in the last 365 days.

Vascular Grafts Companies Invest In Technological Advances For Innovative Products

Vascular Grafts Market Report 2020-30: COVID-19 Growth And Change

Vascular Grafts Global Market Report 2020-30: COVID-19 Growth And Change

The Business Research Company’s Vascular Grafts Global Market Report 2020-30: COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, February 8, 2021 /EINPresswire.com/ -- New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

Companies in the vascular graft market are increasingly investing in technological advances for the development of innovative vascular grafts, including customization of vascular grafts. For instance, RelayPro, a thoracic stent graft system recently launched by Terumo Aortic, is a low-profile device designed for patients with smaller access vessels in the treatment of thoracic endovascular aortic repair (TEVAR). It offers a broad range of diameters, lengths, tapers, and proximal configurations to the physicians. Both bare stent and non-bare stent (NBS) versions are available for this device and it can be customized to meet the patients’ specific anatomical needs. Such vascular graft market trends help advance the market.

The major players with vascular graft industry shares are B. Braun, C. R. Bard, Cardinal Health, Cook Medical, Endologix, LeMaitre Vascular, Medtronic Plc, Getinge, Terumo Medical Corporation, Gore Medical, Getinge AB, Lombard Medical, Becton Dickinson (C.R. Bard), Terumo Medical Corporation, Artegraft, Jotec GmbH, Heart Medical Europe BV, Japan Lifeline, Cardinal Health.

The global vascular grafts market was expected to decline from $2.79 billion in 2019 to $2.6 billion in 2020 at a compound annual growth rate (CAGR) of -6.98%. The decline was mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The vascular graft market size is expected to recover and reach $3.27 billion in 2023 at a CAGR of 8.02%.

Here Is A List Of Similar Reports By The Business Research Company:
Wearable Blood Pressure Monitors Market - By Product (Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor, Finger Blood Pressure Monitor), And By Region, Opportunities And Strategies - Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/wearable-blood-pressure-monitors-market

Pulse Oximeters and Spirometers Market - By Product Type (Pulse Oximeters, Spirometers), Type Of Device (Handheld, Fingertip, Others), By Application (Diagnostic, Treatment Monitoring), By Patient Type (Asthma, COPD, Other General & Surgical Practice, Other Respiratory Diseases), By End-Use (Hospitals, Clinical Laboratories, Home Care), Market Size, Opportunities And Strategies - Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/pulse-oximeters-and-spirometers-market

Cardiovascular Surgery Devices And Equipment Global Market Report 2021: COVID 19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Cardiovascular Medical Lasers Global Market Report 2020-30: COVID 19 Growth and Change
https://www.thebusinessresearchcompany.com/report/cardiovascular-medical-lasers-global-market-report-2020-30-covid-19-growth-and-change

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn